The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
"We are pleased the FDA has accepted our NDA for Bumetanide Nasal Spray," said Benjamin Esque, CEO of Corstasis Therapeutics ...
(HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at ...
WOOD Grand Rapids on MSN23h
Nose spray to treat depression? FDA approves first-of-its-kind medicineThe U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...
More than 1 in 3 parents reported that their child has dealt with dental problems linked to a lack of routine oral hygiene, ...
In accordance with the terms and conditions for warrants of series TO 2, which were issued in connection with the capital raise announced in April 2024, the number of shares that each warrant entitles ...
Matternet, the developer of the world's leading urban drone delivery system, today announced that the company has been approved by The Kingdom of Saudi Arabia to operate its M2 drone within the region ...
Biohaven wielded meals at high-end restaurants and paid speaking opportunities to induce healthcare providers to prescribe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback